News and Events
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers...
CADTH has received the following notice(s) of pending drug submission(s).
MEDEXUS Pharmaceuticals, Inc.
chronic severe drooling, neurologic (pediatric)
Call for patient input
Patient input deadline
Submit patient input
CADTH is pleased to announce the appointment of Dr. Nicole Mittmann, MSc., PhD, as CADTH Chief Scientist and Vice-President of Evidence Standards.
Dr. Mittmann will lead CADTH’s shared science groups, including our Health Economics, Research Information Services, and Scientific Affairs teams. She will also be responsible for building networks wi...
View all News